<DOC>
	<DOCNO>NCT00538525</DOCNO>
	<brief_summary>Phase II study neoadjuvant chemotherapy Doxorubicin follow Docetaxel-Cisplatin locally advance breast cancer</brief_summary>
	<brief_title>Phase II Study Neoadjuvant Chemotherapy With Doxorubicin Followed Docetaxel-Cisplatin Locally Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Patients locally advance breast cancer Patients metastatic breast cancer</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>